Kenya has made substantial advancements in tackling drug-resistant TB (DR-TB), with 750 patients started on second-line treatment.
The introduction of shorter, patient-friendly regimens for multidrug-resistant TB (MDR-TB) and rifampicin-resistant TB (RR-TB) has significantly improved patient adherence and health outcomes.
Speaking Monday during the commemoration of World Tuberculosis (TB) Day 2025, Principal Secretary, State Department for Public Health and Professional Standards Mary Muthoni Muriuki, said Kenya remains a high TB and TB/HIV burden country. "Despite this, we have made commendable strides in combating TB, and in 2024 alone, the National TB Programme diagnosed and initiated treatment for 96,865 individuals, reflecting continued success in TB management," the PS said in a speech read on her behalf by Dr.
Joseph Lenai, Directorate Preventive, Promotive Health Services and Disease Control.
